Staidson (Beijing) Biopharmaceuticals Co (SZSE:300204) FCF Margin % : -23.29% (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Staidson (Beijing) Biopharmaceuticals Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Staidson (Beijing) Biopharmaceuticals Co's Free Cash Flow for the three months ended in Mar. 2024 was ¥-22.1 Mil. Staidson (Beijing) Biopharmaceuticals Co's Revenue for the three months ended in Mar. 2024 was ¥95.0 Mil. Therefore, Staidson (Beijing) Biopharmaceuticals Co's FCF Margin % for the quarter that ended in Mar. 2024 was -23.29%.

As of today, Staidson (Beijing) Biopharmaceuticals Co's current FCF Yield % is -8.62%.

The historical rank and industry rank for Staidson (Beijing) Biopharmaceuticals Co's FCF Margin % or its related term are showing as below:

SZSE:300204' s FCF Margin % Range Over the Past 10 Years
Min: -71.52 Med: 3.15 Max: 17.6
Current: -57.98

During the past 13 years, the highest FCF Margin % of Staidson (Beijing) Biopharmaceuticals Co was 17.60%. The lowest was -71.52%. And the median was 3.15%.

SZSE:300204's FCF Margin % is ranked better than
59.63% of 1038 companies
in the Biotechnology industry
Industry Median: -136.31 vs SZSE:300204: -57.98

Staidson (Beijing) Biopharmaceuticals Co FCF Margin % Historical Data

The historical data trend for Staidson (Beijing) Biopharmaceuticals Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Staidson (Beijing) Biopharmaceuticals Co FCF Margin % Chart

Staidson (Beijing) Biopharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-2.35

-38.44

-37.36

-42.28

-71.52

Staidson (Beijing) Biopharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-83.15	-69.97	-35.10	-107.56	-23.29

Competitive Comparison of Staidson (Beijing) Biopharmaceuticals Co's FCF Margin %

For the Biotechnology subindustry, Staidson (Beijing) Biopharmaceuticals Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Staidson (Beijing) Biopharmaceuticals Co's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Staidson (Beijing) Biopharmaceuticals Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Staidson (Beijing) Biopharmaceuticals Co's FCF Margin % falls into.

Staidson (Beijing) Biopharmaceuticals Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Staidson (Beijing) Biopharmaceuticals Co's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-260.47	/	364.175
	=	-71.52 %

Staidson (Beijing) Biopharmaceuticals Co's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-22.118	/	94.983
	=	-23.29 %

Staidson (Beijing) Biopharmaceuticals Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of Staidson (Beijing) Biopharmaceuticals Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Staidson (Beijing) Biopharmaceuticals Co (SZSE:300204) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Staidson (Beijing) Biopharmaceuticals Co Ltd (SZSE:300204) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Rongjing Dong Street, No 5 Beijing Economic and Technological Development Zone, Beijing, CHN, 100176

Website

http://www.staidson.com

Staidson (Beijing) Biopharmaceuticals Co Ltd is a pharmaceutical company mainly engaged in the research, development, production, and sale of biological products in China. Its products include mouse nerve growth factor injection, intravenous compound polyethylene glycol electrolyte powder solution, gliclazide, nabumetone, and aspirin.

Executives

Zhang Hong Shan	Supervisors
Zheng Hong	Supervisors
Cheng Jiang Hong	Executives
Feng Yu Jing	Executives
Ma Li Na	Secretary, Director
Zhou Zhi Wen	Director
Wang Huan	Securities Affairs Representative
Zhang Rong Qin	Executives
Xu Jiang Ping	Executives
Cao Hai Yan	Supervisors
Sun Yan Fang	Executives
Jiang Li Xin	Director
Gu Jian Ping	Director
Xu Xiang Qing	Supervisors
Gu Zhen Qi	Director

Staidson (Beijing) Biopharmaceuticals Co (SZSE:300204) Headlines

No Headlines